Epithelial-mesenchymal interactions in pulmonary fibrosis

被引:109
作者
Horowitz, Jeffrey C. [1 ]
Thannickal, Victor J. [1 ]
机构
[1] Univ Michigan, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
关键词
fibroblast; myofibroblast; apoptosis; wound repair; extracellular matrix;
D O I
10.1055/s-2006-957332
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Pulmonary fibrosis represents the sequelae of a variety of acute and chronic lung injuries of known and unknown etiologies. Tissue specimens obtained from patients with pulmonary fibrosis, regardless of the etiology, consistently show evidence of an ongoing wound-repair response. Epithelial-mesenchymal interactions have critical roles in normal lung development, tissue repair processes, and fibrosis. Current hypotheses propose that dysregulated function of, and impaired communication between, epithelial and mesenchymal cells prevent resolution of the wound-repair response and contribute to the pathobiology of pulmonary fibrosis. This hypothesis is supported by abundant evidence from patients, animal models, and cell-culture studies demonstrating abnormalities in epithelial cell and mesenchymal cell activities including proliferation, differentiation, and survival. This article reviews the aberrant epithelial and mesenchymal cellular phenotypes found in the context of pulmonary fibrosis and discusses the mechanisms that perpetuate these cellular phenotypes.
引用
收藏
页码:600 / 612
页数:13
相关论文
共 197 条
[1]  
ADAMSON IYR, 1990, AM J PATHOL, V137, P385
[2]   The Fas/Fas-ligand system is not required for bleomycin-induced pulmonary fibrosis in mice [J].
Aoshiba, K ;
Yasui, S ;
Tamaoki, J ;
Nagai, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) :695-700
[3]   Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cells [J].
Bao, SY ;
Wang, YJ ;
Sweeney, P ;
Chaudhuri, A ;
Doseff, AI ;
Marsh, CB ;
Knoell, DL .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 288 (01) :L36-L42
[4]   Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP) [J].
Barbas-Filho, JV ;
Ferreira, MA ;
Sesso, A ;
Kairalla, RA ;
Carvalho, CRR ;
Capelozzi, VL .
JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (02) :132-138
[5]   Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis - Adjunctive therapy to maintenance immunosuppression [J].
Behr, J ;
Maier, K ;
Degenkolb, B ;
Krombach, F ;
Vogelmeier, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (06) :1897-1901
[6]   Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-β and IL-10 [J].
Bergeron, A ;
Soler, P ;
Kambouchner, M ;
Loiseau, P ;
Milleron, B ;
Valeyre, D ;
Hance, AJ ;
Tazi, A .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (01) :69-76
[7]  
BIENKOWSKI RS, 1995, P SOC EXP BIOL MED, V209, P118
[8]   MODULATION OF ALVEOLAR MACROPHAGE DRIVEN FIBROBLAST PROLIFERATION BY ALTERNATIVE MACROPHAGE MEDIATORS [J].
BITTERMAN, PB ;
WEWERS, MD ;
RENNARD, SI ;
ADELBERG, S ;
CRYSTAL, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (03) :700-708
[9]   Progressive transforming growth factor β1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor [J].
Bonniaud, P ;
Margetts, PJ ;
Kolb, M ;
Schroeder, JA ;
Kapoun, AM ;
Damm, D ;
Murphy, A ;
Chakravarty, S ;
Dugar, S ;
Higgins, L ;
Protter, AA ;
Gauldie, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (08) :889-898
[10]   Smad3 null mice develop airspace enlargement and are resistant to TGF-β-mediated pulmonary fibrosis [J].
Bonniaud, P ;
Kolb, M ;
Galt, T ;
Robertson, J ;
Robbins, C ;
Stampfli, M ;
Lavery, C ;
Margetts, PJ ;
Roberts, AB ;
Gauldie, J .
JOURNAL OF IMMUNOLOGY, 2004, 173 (03) :2099-2108